Device leakage: FDA reporting patterns
41,779 FDA FAERS reports mention Device leakage. 5,333 reports have a serious outcome flag.
Medicines named as suspect
- Somatropin: 10,592 reports
- Leuprolide: 6,236 reports
- Exenatide: 5,120 reports
- Pegfilgrastim: 1,446 reports
- Secukinumab: 1,225 reports
- Albiglutide: 1,195 reports
- Device: 1,127 reports
- Risperidone: 990 reports
- Semaglutide: 975 reports
- Treprostinil: 939 reports
- Guselkumab: 920 reports
- Adalimumab: 720 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.